Downregulation of uPAR promotes urokinase translocation into the nucleus and epithelial to mesenchymal transition in neuroblastoma
Authors:
- Ekaterina V. SeminaESEkaterina V. Semina
- Kseniya A. RubinaKRKseniya A. Rubina
- Anna A. ShmakovaASAnna A. Shmakova
- Karina D. RysenkovaKRKarina D. Rysenkova
- Polina S. KlimovichPKPolina S. Klimovich
- Natalya A. AleksanrushkinaNANatalya A. Aleksanrushkina
- Veronika Y. SysoevaVSVeronika Y. Sysoeva
- Maxim N. KaragyaurMKMaxim N. Karagyaur
- Vsevolod A. TkachukVsevolod A. Tkachuk
Open Access
- 28 January 2020
- journal article
- research article
- Published by Wiley in Journal of Cellular Physiology
- Vol. 235 (9) , 6268-6286
Abstract
The urokinase system is involved in a variety of physiological processes, such as fibrinolysis, matrix remodeling, wound healing, and regeneration. Upon binding to its cognate receptor urokinase‐type plasminogen activator receptor (uPAR), urokinase‐type plasminogen activator (uPA) catalyzes the conversion of plasminogen to plasmin and the activation of matrix metalloproteases. Apart from this, uPA–uPAR interaction can lead to the activation of transcription factors, mitogen‐activated protein kinase signaling pathways and RTK cascades. Elevated expression of uPA and uPAR is markedly associated with cancer progression and metastasis and correlates with a poor prognosis in clinics. Targeting the urokinase system has proved to be effective in experimental models in vitro and in vivo, however, in clinics the inhibition of the uPA/uPAR system has fallen short of expectations, suggesting that the question of the functional relevance of uPA/uPAR system is far from being moot. Recently, using CRISPR/Cas9 technology, we have shown that uPAR knockout decreases the proliferation of neuroblastoma Neuro2a cells in vitro. In the present study we demonstrate that uPAR expression is essential for maintaining the epithelial phenotype in Neuro2a cells and that uPAR silencing promotes epithelial‐mesenchymal transition (EMT) and increased cell migration. Accordingly, uPAR knockout results in the downregulation of epithelial markers (E‐cadherin, occludin, and claudin‐5) and in the increase of mesenchymal markers (N‐cadherin, α‐smooth muscle actin, and interleukin‐6). In search of the molecular mechanism underlying these changes, we identified uPA as a key component. Two key insights emerged as a result of this work: in the absence of uPAR, uPA is translocated into the nucleus where it is presumably involved in the activation of transcription factors (nuclear factor κB and Snail) resulting in EMT. In uPAR‐expressing cells, uPAR functions as a uPA “trap” that binds uPA on the cell surface and promotes controlled uPA internalization and degradation in lysosomes.Keywords
Funding Information
- Russian Science Foundation (19‐75‐30007)
This publication has 79 references indexed in Scilit:
- A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self‐renewalThe EMBO Journal, 2013
- Snail1 controls epithelial–mesenchymal lineage commitment in focal adhesion kinase–null embryonic cellsJournal of Cell Biology, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- The urokinase receptor: Focused cell surface proteolysis, cell adhesion and signalingFEBS Letters, 2009
- Epithelial-Mesenchymal Transitions in Development and DiseaseCell, 2009
- Reversibility of Epithelial-Mesenchymal Transition (EMT) Induced in Breast Cancer Cells by Activation of Urokinase Receptor-dependent Cell SignalingJournal of Biological Chemistry, 2009
- The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem CellsCell, 2008
- uPAR induces epithelial–mesenchymal transition in hypoxic breast cancer cellsJournal of Cell Biology, 2007
- In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitroNature Protocols, 2007
- Downregulation of uPA, uPAR and MMP-9 using small, interfering, hairpin RNA (siRNA) inhibits glioma cell invasion, angiogenesis and tumor growthNeuron Glia Biology, 2004